Magnesium in PDB 6p8q: Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor.
Enzymatic activity of Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor.
All present enzymatic activity of Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor.:
2.7.10.1;
Protein crystallography data
The structure of Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor., PDB code: 6p8q
was solved by
C.H.Yun,
D.E.Heppner,
M.J.Eck,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
21.44 /
1.90
|
Space group
|
P 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
57.151,
72.874,
79.927,
100.16,
103.16,
95.61
|
R / Rfree (%)
|
16.8 /
19.5
|
Other elements in 6p8q:
The structure of Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor. also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor.
(pdb code 6p8q). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 5 binding sites of Magnesium where determined in the
Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor., PDB code: 6p8q:
Jump to Magnesium binding site number:
1;
2;
3;
4;
5;
Magnesium binding site 1 out
of 5 in 6p8q
Go back to
Magnesium Binding Sites List in 6p8q
Magnesium binding site 1 out
of 5 in the Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg2003
b:28.5
occ:1.00
|
NZ
|
A:LYS745
|
3.0
|
23.6
|
1.0
|
O1A
|
A:ANP2001
|
3.1
|
20.2
|
1.0
|
O
|
A:HOH2232
|
3.1
|
33.1
|
1.0
|
N
|
A:PHE723
|
3.2
|
26.5
|
1.0
|
N
|
A:GLY724
|
3.5
|
26.5
|
1.0
|
N
|
A:ALA722
|
3.6
|
31.5
|
1.0
|
O1G
|
A:ANP2001
|
3.6
|
21.9
|
1.0
|
CE
|
A:LYS745
|
3.6
|
23.6
|
1.0
|
CA
|
A:PHE723
|
3.8
|
30.2
|
1.0
|
CA
|
A:GLY721
|
3.8
|
23.8
|
1.0
|
C
|
A:GLY721
|
3.8
|
27.6
|
1.0
|
CB
|
A:PHE723
|
3.9
|
29.8
|
1.0
|
C
|
A:PHE723
|
4.0
|
28.8
|
1.0
|
O2A
|
A:ANP2001
|
4.1
|
26.8
|
1.0
|
CD2
|
A:LEU858
|
4.1
|
28.0
|
1.0
|
PA
|
A:ANP2001
|
4.1
|
26.8
|
1.0
|
C
|
A:ALA722
|
4.2
|
30.4
|
1.0
|
N
|
A:GLY721
|
4.2
|
27.2
|
1.0
|
O
|
A:GLY724
|
4.3
|
25.8
|
1.0
|
CD2
|
A:PHE723
|
4.4
|
31.3
|
1.0
|
CA
|
A:GLY724
|
4.4
|
28.2
|
1.0
|
CD
|
A:LYS745
|
4.4
|
22.2
|
1.0
|
CA
|
A:ALA722
|
4.4
|
31.3
|
1.0
|
O
|
A:HOH2101
|
4.4
|
28.5
|
1.0
|
O3A
|
A:ANP2001
|
4.4
|
24.5
|
1.0
|
O
|
A:GLY721
|
4.4
|
21.6
|
1.0
|
CG
|
A:PHE723
|
4.6
|
37.0
|
1.0
|
C
|
A:GLY724
|
4.6
|
22.6
|
1.0
|
O2G
|
A:ANP2001
|
4.7
|
22.1
|
0.8
|
PG
|
A:ANP2001
|
4.8
|
21.5
|
0.6
|
CB
|
A:ALA722
|
4.8
|
32.1
|
1.0
|
|
Magnesium binding site 2 out
of 5 in 6p8q
Go back to
Magnesium Binding Sites List in 6p8q
Magnesium binding site 2 out
of 5 in the Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg2004
b:16.2
occ:0.56
|
O1B
|
A:ANP2001
|
1.9
|
21.1
|
0.8
|
O2A
|
A:ANP2001
|
2.0
|
26.8
|
1.0
|
O2G
|
A:ANP2001
|
2.0
|
22.1
|
0.8
|
OD1
|
A:ASN842
|
2.2
|
15.4
|
1.0
|
O
|
A:HOH2181
|
2.2
|
32.7
|
1.0
|
OD2
|
A:ASP855
|
2.3
|
26.4
|
1.0
|
PB
|
A:ANP2001
|
2.9
|
21.7
|
0.5
|
PA
|
A:ANP2001
|
3.0
|
26.8
|
1.0
|
O3A
|
A:ANP2001
|
3.2
|
24.5
|
1.0
|
CG
|
A:ASN842
|
3.3
|
16.4
|
1.0
|
PG
|
A:ANP2001
|
3.3
|
21.5
|
0.6
|
CG
|
A:ASP855
|
3.5
|
25.5
|
1.0
|
O5'
|
A:ANP2001
|
3.6
|
24.9
|
1.0
|
N3B
|
A:ANP2001
|
3.6
|
23.7
|
0.5
|
O
|
A:HOH2101
|
3.7
|
28.5
|
1.0
|
ND2
|
A:ASN842
|
3.8
|
10.2
|
1.0
|
O
|
A:HOH2232
|
3.9
|
33.1
|
1.0
|
O
|
A:HOH2122
|
3.9
|
28.1
|
1.0
|
O
|
A:HOH2184
|
4.0
|
28.3
|
1.0
|
O
|
A:ARG841
|
4.1
|
14.0
|
1.0
|
O2B
|
A:ANP2001
|
4.2
|
22.1
|
0.7
|
O1G
|
A:ANP2001
|
4.3
|
21.9
|
1.0
|
O1A
|
A:ANP2001
|
4.3
|
20.2
|
1.0
|
O3G
|
A:ANP2001
|
4.3
|
18.5
|
0.9
|
OD1
|
A:ASP855
|
4.3
|
29.6
|
1.0
|
CB
|
A:ASP855
|
4.4
|
15.0
|
1.0
|
CB
|
A:ASN842
|
4.5
|
14.5
|
1.0
|
CA
|
A:ASN842
|
4.7
|
13.6
|
1.0
|
C
|
A:ARG841
|
4.7
|
17.4
|
1.0
|
O
|
A:HOH2197
|
4.8
|
20.0
|
1.0
|
CG
|
A:ARG841
|
4.9
|
12.9
|
1.0
|
C5'
|
A:ANP2001
|
4.9
|
24.1
|
1.0
|
N
|
A:ASN842
|
5.0
|
14.1
|
1.0
|
|
Magnesium binding site 3 out
of 5 in 6p8q
Go back to
Magnesium Binding Sites List in 6p8q
Magnesium binding site 3 out
of 5 in the Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg2003
b:18.0
occ:1.00
|
O2P
|
B:AMP2001
|
2.9
|
17.3
|
1.0
|
NZ
|
B:LYS745
|
3.0
|
17.9
|
1.0
|
N
|
B:PHE723
|
3.3
|
23.2
|
1.0
|
N
|
B:GLY724
|
3.4
|
18.9
|
1.0
|
O
|
B:HOH2312
|
3.5
|
31.4
|
1.0
|
CA
|
B:GLY721
|
3.6
|
22.4
|
1.0
|
N
|
B:ALA722
|
3.7
|
24.5
|
1.0
|
C
|
B:GLY721
|
3.7
|
24.7
|
1.0
|
CE
|
B:LYS745
|
3.7
|
14.8
|
1.0
|
CB
|
B:PHE723
|
3.8
|
23.4
|
1.0
|
CA
|
B:PHE723
|
3.8
|
20.6
|
1.0
|
C
|
B:PHE723
|
3.9
|
23.6
|
1.0
|
CD2
|
B:LEU858
|
4.0
|
26.1
|
1.0
|
P
|
B:AMP2001
|
4.0
|
20.3
|
1.0
|
O
|
B:GLY724
|
4.0
|
23.6
|
1.0
|
O1P
|
B:AMP2001
|
4.2
|
21.7
|
1.0
|
N
|
B:GLY721
|
4.2
|
25.8
|
1.0
|
O3P
|
B:AMP2001
|
4.2
|
24.2
|
1.0
|
CD
|
B:LYS745
|
4.2
|
16.5
|
1.0
|
CA
|
B:GLY724
|
4.3
|
23.8
|
1.0
|
CD2
|
B:PHE723
|
4.3
|
26.6
|
1.0
|
O
|
B:GLY721
|
4.3
|
18.1
|
1.0
|
C
|
B:ALA722
|
4.4
|
28.9
|
1.0
|
CA
|
B:ALA722
|
4.5
|
23.7
|
1.0
|
CG
|
B:PHE723
|
4.5
|
26.1
|
1.0
|
C
|
B:GLY724
|
4.5
|
21.7
|
1.0
|
O
|
B:HOH2164
|
4.7
|
41.1
|
1.0
|
O
|
B:PHE723
|
4.9
|
25.2
|
1.0
|
O
|
B:HOH2105
|
4.9
|
29.8
|
1.0
|
OD2
|
B:ASP855
|
4.9
|
23.9
|
1.0
|
|
Magnesium binding site 4 out
of 5 in 6p8q
Go back to
Magnesium Binding Sites List in 6p8q
Magnesium binding site 4 out
of 5 in the Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg2003
b:10.5
occ:1.00
|
O2P
|
C:AMP2001
|
3.0
|
18.2
|
1.0
|
NZ
|
C:LYS745
|
3.0
|
12.9
|
1.0
|
O
|
C:HOH2310
|
3.2
|
20.9
|
1.0
|
N
|
C:PHE723
|
3.3
|
16.5
|
1.0
|
N
|
C:GLY724
|
3.5
|
16.5
|
1.0
|
CA
|
C:GLY721
|
3.6
|
16.2
|
1.0
|
C
|
C:GLY721
|
3.7
|
18.8
|
1.0
|
N
|
C:ALA722
|
3.7
|
16.7
|
1.0
|
CE
|
C:LYS745
|
3.8
|
11.5
|
1.0
|
CB
|
C:PHE723
|
3.9
|
15.1
|
1.0
|
CA
|
C:PHE723
|
3.9
|
18.1
|
1.0
|
CD2
|
C:LEU858
|
3.9
|
21.8
|
1.0
|
P
|
C:AMP2001
|
3.9
|
16.7
|
1.0
|
O
|
C:GLY724
|
4.0
|
16.9
|
1.0
|
C
|
C:PHE723
|
4.0
|
21.8
|
1.0
|
O1P
|
C:AMP2001
|
4.1
|
15.5
|
1.0
|
N
|
C:GLY721
|
4.2
|
18.0
|
1.0
|
O3P
|
C:AMP2001
|
4.2
|
17.3
|
1.0
|
CD
|
C:LYS745
|
4.2
|
13.8
|
1.0
|
O
|
C:GLY721
|
4.3
|
18.5
|
1.0
|
CA
|
C:GLY724
|
4.3
|
18.9
|
1.0
|
CD2
|
C:PHE723
|
4.3
|
18.4
|
1.0
|
C
|
C:ALA722
|
4.4
|
18.5
|
1.0
|
O
|
C:HOH2154
|
4.4
|
30.6
|
1.0
|
C
|
C:GLY724
|
4.5
|
18.3
|
1.0
|
CG
|
C:PHE723
|
4.6
|
17.5
|
1.0
|
CA
|
C:ALA722
|
4.6
|
20.4
|
1.0
|
O
|
C:HOH2117
|
4.6
|
20.8
|
1.0
|
OD2
|
C:ASP855
|
4.9
|
16.2
|
1.0
|
O
|
C:PHE723
|
5.0
|
17.7
|
1.0
|
|
Magnesium binding site 5 out
of 5 in 6p8q
Go back to
Magnesium Binding Sites List in 6p8q
Magnesium binding site 5 out
of 5 in the Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor.
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 5 of Egfr in Complex with A Dihydrodibenzodiazepinone Allosteric Inhibitor. within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Mg2003
b:22.5
occ:1.00
|
O2P
|
D:AMP2001
|
3.1
|
27.4
|
1.0
|
NZ
|
D:LYS745
|
3.1
|
23.8
|
1.0
|
N
|
D:GLY724
|
3.3
|
27.2
|
1.0
|
N
|
D:PHE723
|
3.4
|
27.3
|
1.0
|
CA
|
D:GLY721
|
3.6
|
28.7
|
1.0
|
O
|
D:HOH2258
|
3.6
|
38.6
|
1.0
|
CE
|
D:LYS745
|
3.7
|
16.0
|
1.0
|
C
|
D:GLY721
|
3.8
|
30.4
|
1.0
|
N
|
D:ALA722
|
3.8
|
28.6
|
1.0
|
CD1
|
D:LEU858
|
3.9
|
30.8
|
1.0
|
CA
|
D:PHE723
|
3.9
|
28.1
|
1.0
|
C
|
D:PHE723
|
4.0
|
27.4
|
1.0
|
CB
|
D:PHE723
|
4.0
|
21.6
|
1.0
|
P
|
D:AMP2001
|
4.0
|
30.1
|
1.0
|
O
|
D:GLY724
|
4.0
|
25.4
|
1.0
|
N
|
D:GLY721
|
4.1
|
32.9
|
1.0
|
CA
|
D:GLY724
|
4.1
|
25.8
|
1.0
|
O1P
|
D:AMP2001
|
4.1
|
26.3
|
1.0
|
O3P
|
D:AMP2001
|
4.2
|
35.0
|
1.0
|
CD2
|
D:PHE723
|
4.2
|
29.2
|
1.0
|
CD
|
D:LYS745
|
4.3
|
17.0
|
1.0
|
C
|
D:GLY724
|
4.4
|
24.2
|
1.0
|
O
|
D:GLY721
|
4.4
|
29.6
|
1.0
|
C
|
D:ALA722
|
4.5
|
29.7
|
1.0
|
O
|
D:HOH2257
|
4.5
|
36.4
|
1.0
|
CG
|
D:PHE723
|
4.6
|
22.9
|
1.0
|
CA
|
D:ALA722
|
4.7
|
28.8
|
1.0
|
O
|
D:HOH2114
|
4.9
|
32.2
|
1.0
|
|
Reference:
D.J.H.De Clercq,
D.E.Heppner,
C.To,
J.Jang,
E.Park,
C.H.Yun,
M.Mushajiang,
B.H.Shin,
T.W.Gero,
D.A.Scott,
P.A.Janne,
M.J.Eck,
N.S.Gray.
Discovery and Optimization of Dibenzodiazepinones As Allosteric Mutant-Selective Egfr Inhibitors. Acs Med.Chem.Lett. V. 10 1549 2019.
ISSN: ISSN 1948-5875
PubMed: 31749909
DOI: 10.1021/ACSMEDCHEMLETT.9B00381
Page generated: Tue Oct 1 13:58:53 2024
|